Depo Provera 150mg Injection

Depo-Provera 150 mg/mL Injection contains medroxyprogesterone acetate, a synthetic progestogen used for long-acting hormonal contraception. It works primarily by suppressing ovulation, helping prevent pregnancy.

The medicine is supplied as a sterile injectable suspension containing 150 mg of medroxyprogesterone acetate per mL. The contraceptive injection is administered intramuscularly by a qualified healthcare professional according to the approved product instructions.

Product Information

Product Name

Depo-Provera Injection

Active Ingredient

Medroxyprogesterone acetate

Strength

150 mg/mL

Dosage Form

Sterile injectable suspension

Drug Class

Progestogen (progestin)

Route of Administration

Intramuscular injection

Primary Indication

Prevention of pregnancy

Brand

Depo-Provera

Pack Presentation

Vial or prefilled syringe, depending on the market

Prescription Requirement

Subject to local regulations

Ordering and Availability

For Depo-Provera 150 mg/mL injection prices, pack sizes and availability, contact the supplier to confirm the exact presentation, manufacturer, stock status and applicable documentation requirements.

Availability, regulatory authorization, prescription requirements and import eligibility vary by country. Confirm local regulations and obtain the medicine through an authorized pharmacy or eligible healthcare supplier.

Depo-Provera 150 mg/mL is used for:

• Pregnancy Prevention: Provides long-acting hormonal contraception after administration.
• Convenient Dosing Schedule: In commonly approved regimens, the injection is repeated approximately every 12–13 weeks, according to the local product label and healthcare professional's instructions.
• Non-Daily Contraception: Does not require taking a contraceptive tablet every day.

The injection does not protect against sexually transmitted infections. Discuss the most appropriate contraceptive method with a healthcare professional.

Depo-Provera 150 mg/mL is administered as a deep intramuscular injection by a qualified healthcare professional.

For the US-labeled product, the usual dose for contraception is 150 mg every 3 months (13 weeks). Injection timing and instructions may vary with the local product label and individual circumstances.

Do not administer the injection yourself unless a specifically authorized product and a healthcare professional's instructions permit it. Before the first injection and before subsequent doses when indicated, the healthcare professional should assess pregnancy possibility and confirm appropriate timing.

Storage Instructions

Store the product according to the manufacturer's instructions on the package and official product leaflet. Protect it from unsuitable storage conditions and do not freeze it unless the specific product instructions state otherwise.

The injection should be inspected and prepared by a qualified healthcare professional before administration. Do not use damaged, expired or improperly stored products.

Possible side effects include:

• Irregular menstrual bleeding or spotting
• Changes in menstrual periods, including absent periods
• Weight gain
• Headache or dizziness
• Abdominal discomfort
• Changes in mood or libido
• Delayed return to fertility after the last injection

Long-term use may reduce bone mineral density. Discuss the benefits and risks of continued use with your healthcare professional.

Seek urgent medical attention for severe allergic reactions, sudden chest pain, difficulty breathing, severe headache, sudden visual changes or other serious or unexpected symptoms.

Before using Depo-Provera, inform your healthcare professional about your medical history, current medicines and any possibility of pregnancy.

The injection may be unsuitable for people with known or suspected pregnancy, unexplained vaginal bleeding, certain hormone-sensitive cancers, significant liver disease or specific thromboembolic conditions. The product information also includes important precautions concerning meningioma.

The US product labeling warns about loss of bone mineral density and does not recommend long-term use beyond two years unless other contraceptive options are considered inadequate. Treatment should be reviewed periodically with a healthcare professional.

Return to fertility may be delayed after the final injection. Discuss this possibility when choosing a contraceptive method, especially if pregnancy is planned in the near future.